5 Oct 2026 · 1 hr 2 minNew
Can India make cancer care more affordable?
The Supreme Court has called out the rampant profiteering in the healthcare sector, including cancer medication. Terming the overpricing of essential cancer medicines as “broad, daylight dacoity”, the court said, “This is carnage. Plain and simple. The cancer drug is priced at an MRP of Rs 27,000 despite being supplied to retailers for Rs 2,700.” Ten times higher markup! It also suggested capping the profit margin for all medicines at 16%. India’s cancer burden is growing at an alarming rate. Every year, we record 15.6 lakh new cancer cases, and 9 lakh deaths due to cancer. More than 90% of…





